12-Hydroxystearic acid: A peroxisome proliferator-activated receptor ligand that has antimelanogenic and antiinflammatory activity

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

Cardiovascular Diabetology ◽

10.1186/1475-2840-8-5 ◽

2009 ◽

Vol 8 (1) ◽

pp. 5 ◽

Cited By ~ 9

Author(s):

Koichi Node ◽

Teruo Inoue ◽

Valentin Boyko ◽

Ilan Goldberg ◽

Enrique Z Fisman ◽

...

Keyword(s):

Natriuretic Peptide ◽

Functional Capacity ◽

Peroxisome Proliferator ◽

Long Term Effects ◽

Receptor Ligand ◽

Dependence of Peroxisome Proliferator-activated Receptor Ligand-induced Mitogen-activated Protein Kinase Signaling on Epidermal Growth Factor Receptor Transactivation

Journal of Biological Chemistry ◽

10.1074/jbc.m307827200 ◽

2003 ◽

Vol 278 (47) ◽

pp. 46261-46269 ◽

Cited By ~ 75

Author(s):

Olivia S. Gardner ◽

Brian J. Dewar ◽

H. Shelton Earp ◽

James M. Samet ◽

Lee M. Graves

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor Receptor ◽

Mitogen Activated Protein Kinase ◽

Peroxisome Proliferator ◽

Receptor Ligand ◽

Mitogen Activated Protein ◽

Epidermal Growth ◽

Protein Kinase Signaling ◽

Receptor Transactivation

Effects of Peroxisome Proliferator-Activated Receptor Ligand and Brown Seaweed Based Compound on Megakaryocyte

Clinical & Experimental Thrombosis and Hemostasis ◽

10.14345/ceth.19001 ◽

2019 ◽

Vol 5 (1) ◽

pp. 1-7

Author(s):

Jae-Lim Choi ◽

Ri-Young Goh ◽

Seong-Hoon Yun ◽

Joo-In Park ◽

Jin-Yeong Han

Keyword(s):

Brown Seaweed ◽

Peroxisome Proliferator ◽

Receptor Ligand ◽

Peroxisome Proliferator–Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease

Circulation ◽

10.1161/01.cir.0000126824.12785.b6 ◽

2004 ◽

Vol 109 (18) ◽

pp. 2197-2202 ◽

Cited By ~ 106

Author(s):

Alexander Tenenbaum ◽

Michael Motro ◽

Enrique Z. Fisman ◽

Ehud Schwammenthal ◽

Yehuda Adler ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Coronary Artery Disease ◽

Type 2 Diabetes Mellitus ◽

Coronary Artery ◽

Peroxisome Proliferator ◽

Receptor Ligand ◽

Artery Disease

Successful treatment with fenofibrate, a peroxisome proliferator activated receptor ligand, for a patient with rheumatoid arthritis

Annals of the Rheumatic Diseases ◽

10.1136/ard.2003.015008 ◽

2004 ◽

Vol 63 (8) ◽

pp. 1002-1003 ◽

Cited By ~ 12

Author(s):

H Okamoto

Keyword(s):

Rheumatoid Arthritis ◽

Successful Treatment ◽

Peroxisome Proliferator ◽

Receptor Ligand ◽

Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor ligand

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.0408384102 ◽

2005 ◽

Vol 102 (7) ◽

pp. 2340-2345 ◽

Cited By ~ 307

Author(s):

F. J. Schopfer ◽

Y. Lin ◽

P. R. S. Baker ◽

T. Cui ◽

M. Garcia-Barrio ◽

...

Keyword(s):

Peroxisome Proliferator ◽

Receptor Ligand ◽

Nitrolinoleic Acid

Protective Effects of Peroxisome Proliferator-Activated Receptor ?? Ligand on Apoptosis and Hepatocyte Growth Factor Induction in Renal Ischemia-Reperfusion Injury

Transplantation Journal ◽

10.1097/01.tp.0000269614.21367.3f ◽

2007 ◽

Vol 84 (2) ◽

pp. 207-213 ◽

Cited By ~ 18

Author(s):

Shigehiro Doi ◽

Takao Masaki ◽

Tetsuji Arakawa ◽

Shunsuke Takahashi ◽

Toru Kawai ◽

...

Keyword(s):

Growth Factor ◽

Hepatocyte Growth Factor ◽

Ischemia Reperfusion Injury ◽

Ischemia Reperfusion ◽

Peroxisome Proliferator ◽

Protective Effects ◽

Receptor Ligand ◽

Renal Ischemia Reperfusion Injury ◽

Hepatocyte Growth

Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-08-0173 ◽

2008 ◽

Vol 7 (9) ◽

pp. 2779-2787 ◽

Cited By ~ 13

Author(s):

K. Yamaguchi ◽

M. Cekanova ◽

M. F. McEntee ◽

J.-H. Yoon ◽

S. M. Fischer ◽

...

Keyword(s):

Peroxisome Proliferator ◽

Receptor Ligand ◽

Extracellular Signal Regulated Kinase ◽

Intestinal Polyps ◽

Extracellular Signal

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor- ligand troglitazone in patients with liposarcoma

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.96.7.3951 ◽

1999 ◽

Vol 96 (7) ◽

pp. 3951-3956 ◽

Cited By ~ 337

Author(s):

G. D. Demetri ◽

C. D. M. Fletcher ◽

E. Mueller ◽

P. Sarraf ◽

R. Naujoks ◽

...

Keyword(s):

Solid Tumor ◽

Peroxisome Proliferator ◽

Tumor Differentiation ◽

Receptor Ligand ◽

Combination Therapy of Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-? Ligand, and NMDA Receptor Antagonist (MK-801) on Experimental Embolic Stroke in Rats

Basic & Clinical Pharmacology & Toxicology ◽

10.1111/j.1742-7843.2007.00127.x ◽

2007 ◽

Vol 101 (5) ◽

pp. 309-314 ◽

Cited By ~ 24

Author(s):

Mohammad Allahtavakoli ◽

Alireza Shabanzadeh ◽

Ali Roohbakhsh ◽

Aliasghar Pourshanazari

Keyword(s):

Nmda Receptor ◽

Combination Therapy ◽

Receptor Antagonist ◽

Nmda Receptor Antagonist ◽

Embolic Stroke ◽

Peroxisome Proliferator ◽

Receptor Ligand ◽

Mk 801